EGFR Modulates Complement Activation in Head and Neck Squamous Cell Carcinoma

BMC Cancer - United Kingdom
doi 10.1186/s12885-020-6615-z
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

PET of EGFR Antibody Distribution in Head and Neck Squamous Cell Carcinoma Models

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2009English

Head and Neck: Oral Squamous Cell Carcinoma

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2011English

SOX2 Activation Predicts Prognosis in Patients With Head and Neck Squamous Cell Carcinoma

Scientific Reports
Multidisciplinary
2018English

Head and Neck Squamous Cell Carcinoma Survivorship Care

2019English

Co-Targeting EGFR and IKKβ/NF-κB Signalling Pathways in Head and Neck Squamous Cell Carcinoma: A Potential Novel Therapy for Head and Neck Squamous Cell Cancer

British Journal of Cancer
Cancer ResearchOncology
2018English

Immunotherapy for Head and Neck Squamous Cell Carcinoma

Memo - Magazine of European Medical Oncology
OncologyHematology
2016English

Head and Neck Squamous Cell Carcinoma in Pregnant Women

Laryngoscope
Otorhinolaryngology
2011English

Detection of EGFR- And HER2-activating Mutations in Squamous Cell Carcinoma Involving the Head and Neck

Modern Pathology
Forensic MedicinePathology
2006English

Cutaneous Squamous Cell Carcinoma of the Head and Neck

Journal of Skin Cancer
DermatologyOncology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy